|
Video: What is a Stock Split?
|
|
vTv Therapeutics is a holding company. Through its subsidiary, vTv Therapeutics LLC, Co. is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for diabetes. Co. has a pipeline of small molecule clinical and pre-clinical drug candidates. Co.'s primary program is TTP399, an orally administered, small molecule, liver-selective glucokinase activator for the treatment of type 1 diabetes. In addition to the studies of TTP399, Co. is conducting a Phase 1 mechanistic study of TTP399 in patients with type 1 diabetes to determine the impact of TTP399 on ketone body formation during a period of acute insulin withdrawal. According to our VTVT split history records, vTv Therapeutics has had 1 split. | |
|
vTv Therapeutics (VTVT) has 1 split in our VTVT split history database. The split for VTVT took place on November 21, 2023. This was a 1 for 40 reverse split, meaning for each 40 shares of VTVT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 25 share position following the split.
When a company such as vTv Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the VTVT split history from start to finish, an original position size of 1000 shares would have turned into 25 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into vTv Therapeutics shares, starting with a $10,000 purchase of VTVT, presented on a split-history-adjusted basis factoring in the complete VTVT split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/05/2015 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$400.00 |
|
End price/share: |
$26.96 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-93.26% |
|
Average Annual Total Return: |
-26.57% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$674.33 |
|
Years: |
8.73 |
|
|
|
Date |
Ratio |
11/21/2023 | 1 for 40 |
|
|